Back
SpringWorks Therapeutics Stock Predictions

The Tariff-Proof Asset in Your Pocket
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
11
SWTX
SpringWorks Therapeutics
Last Price:
$38.21
Seasonality Move:
5.59%
7 Day Trial
ALL ACCESS PASS
$
7

Crowdfunding to IPO: Nasdaq's Next Breakout?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.SpringWorks Therapeutics Stock Forecast
-
Over the next 52 weeks, SpringWorks Therapeutics has on average historically risen by 44.4% based on the past 5 years of stock performance.
-
SpringWorks Therapeutics has risen higher in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
-
Is SpringWorks Therapeutics Stock Undervalued?The current SpringWorks Therapeutics [SWTX] share price is $36.99. The Score for SWTX is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.
-
SWTX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
Will SpringWorks Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, SpringWorks Therapeutics has on average historically risen by 44.4% based on the past 5 years of stock performance.
SpringWorks Therapeutics Stock Rating
Sell
11
SpringWorks Therapeutics (SWTX)
is a Sell
Is SpringWorks Therapeutics overpriced?
-
SpringWorks Therapeutics has risen higher in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
SpringWorks Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
springworkstx.com
52-Week Data
52-Week High:
62.00
52-Week Low:
28.21
Prediction Charts
Market Cap:
2.8B
Price in USD:
36.99
Volume:
3.1M
Beta:
0.92
Technical Analysis
SMA50:
47.64
SMA100:
42.67
SMA200:
39.14
52-Wk Change:
-16.86%
Stock Predictions
-
Is SpringWorks Therapeutics stock public?Yes, SpringWorks Therapeutics is a publicly traded company.
-
What is the SpringWorks Therapeutics stock quote today?The SpringWorks Therapeutics stock price is 36.99 USD today.
-
How to buy SpringWorks Therapeutics stock online?You can buy SpringWorks Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Mar-19 | 49.00 | 50.63 | 50.88 | 48.90 |
Mar-20 | 50.19 | 51.08 | 51.43 | 50.15 |
Mar-21 | 50.71 | 49.89 | 50.71 | 49.53 |
Mar-24 | 49.97 | 48.51 | 50.34 | 48.36 |
Mar-25 | 48.51 | 47.21 | 48.62 | 46.98 |
Mar-26 | 47.51 | 46.48 | 47.51 | 45.88 |
Mar-27 | 46.65 | 47.49 | 47.88 | 46.47 |
Mar-28 | 47.52 | 47.41 | 47.88 | 46.00 |
Mar-31 | 45.70 | 44.13 | 46.00 | 43.76 |
Apr-1 | 43.94 | 41.88 | 44.18 | 40.98 |
Apr-2 | 41.30 | 46.52 | 46.95 | 41.30 |
Apr-3 | 45.00 | 43.07 | 46.16 | 43.05 |
Apr-4 | 41.55 | 39.09 | 42.44 | 38.57 |
Apr-7 | 37.40 | 36.99 | 39.90 | 35.72 |
SpringWorks Therapeutics Earnings
SpringWorks Therapeutics Earnings Report: Per Share SpringWorks Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
SpringWorks Therapeutics Forecast Revenue Growth
SpringWorks Therapeutics Stock Analysis: Historical quarterly revenues per share for SpringWorks Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.72 per share, and an increase next year of $2.06 per share.
* SpringWorks Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.